Kineta Inc.

UEI
NSHPJSN74LP8
CAGE
50NT6
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
kinetabio.com
Founded
2008
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Award the contract titled: "development of innate immune agonists as broad spectrum small molecule antivirals" for… HHSN272201500011C National Institute of Allergy and Infectious Diseases (NIH) $3,676,853
Contracts sbir (10-8469728) HHSN268201000052C National Institute of Environmental Health Sciences (NIH) $1,226,941

Grant awards

Award Agency Obligated Awarded
Advanced development of a viral entry inhibitor as a therapeutic for arenavirus hemorrhagic fever R01AI141102 National Institute of Allergy and Infectious Diseases (NIH) $10,300,480
Small-molecule agonists of the RIG-i-like receptor pathway as cancer immunotherapeutics R44CA213567 National Cancer Institute (NIH) $1,500,000
Small-molecule agonists of the RIG-i-like receptor pathway as cancer immunotherapeutics R43CA213567 National Cancer Institute (NIH) $225,000
Development of an alpha-conotoxin rgia analog as a novel, non-opioid therapeutic for chronic neuropathic pain R43DA045413 National Institute on Drug Abuse (NIH) $225,000
Therapeutic potential of the potassium channel inhibitor SHK-186 for pediatric lupus R41AI122566 National Institutes of Health $224,977

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Kineta Inc. registered in SAM.gov?

Kineta Inc.'s SAM.gov registration expired on November 7, 2023.

What is Kineta Inc.'s most recent federal award?

Kineta Inc.'s most recent federal grant award is Advanced development of a viral entry inhibitor as a therapeutic for arenavirus hemorrhagic fever (R01AI141102), from National Institute of Allergy and Infectious Diseases (NIH), on January 1, 2019.

On GovTribe

See Kineta Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login